Reactive protoplasmic and fibrous astrocytes contain high levels of calpain-cleaved alpha 2 spectrin

Experimental and Molecular Pathology

Volumn 100, Issue 1, 2016, Pages 1-7

  Kim, Jung H ^a   Kwon, Soojung J ^a   Stankewich, Michael C ^a   Huh, Gi Yeong ^b   Glantz, Susan B ^a   Morrow, Jon S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Activated astrocytes; Breakdown product; Calpain; Fibrous astrocytes; Protoplasmic astrocytes; Reactive astrocytes; Spectrin

Indexed keywords

ALPHAII SPECTRIN BREAKDOWN PRODUCT; CALPAIN; GLIAL FIBRILLARY ACIDIC PROTEIN; SPECTRIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL ACTIVATION; CELL TRANSFORMATION; CHILD; CONTROLLED STUDY; FEMALE; FIBROUS ASTROCYTE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTOPLASMIC ASTROCYTE; WHITE MATTER; BRAIN; CYTOPLASM; METABOLISM; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTES; BRAIN; CALPAIN; CYTOPLASM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SPECTRIN;

EID: 84949185428     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.11.005     Document Type: Article

References (69)

1. Agulhon C., et al. Calcium signaling and gliotransmission in normal vs reactive astrocytes. Front. Pharmacol. 2012, 3:1-16.
2. Ahmed B.Y., et al. A chronological study of the expression of glial fibrillary acidic protein and calbindin-D28k by reactive astrocytes in the electrically lesioned rat brain. Neurosci. Res. 1996, 26:271-278.
3. Arai A., et al. A brief period of hypoxia causes proteolysis of cytoskeletal proteins in hippocampal slices. Brain Res. 1991, 555:276-280.
4. Bartus R.T., et al. Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 1995, 15:969-979.
5. Bennett V., Healy J. Membrane domains based on ankyrin and spectrin associated with cell-cell interactions. Cold Spring Harb. Perspect. Biol. 2009, 1(6). Dec. Epub 2009 Aug 19. 10.1101/cshperspect.a003012.
6. Berghs S., et al. Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6945-6950.
7. Bernardinelli Y., et al. Astrocytes display complex and localized calcium responses to single-neuron stimulation in the hippocampus. J. Neurosci. 2011, 31:8905-8991.
8. Bignami A., Dahl D. The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFAP) in mammalian and submammalian vertebrates. Neuropathol. Appl. Neurobiol. 1976, 2:99-110.
9. Buffo A., et al. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem. Pharmacol. 2010, 79:77-89.
10. Colangelo A.N., et al. Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci. Lett. 2014, 565:59-64.
11. De Matteis M.A., Morrow J.S. Spectrin tethers and mesh in the biosynthetic pathway. J. Cell Sci. 2000, 113:2331-2343.
12. Deitmer J.W., et al. Calcium signaling in glial cells. Cell Calcium 1998, 24:405-416.
13. Di Stasi A.M., et al. Neuronal fodrin proteolysis occurs independently of excitatory amino acid-induced neurotoxicity. Neuron 1991, 6:445-454.
14. Dick K.A., et al. Spinocerebellar ataxia type 5. Handb. Clin. Neurol. 2012, 103:451-459.
15. Du S., et al. Calcium influx and activation of calpain I mediate acute reactive gliosis in injured spinal cord. Exp. Neurol. 1999, 157:96-105.
16. Eng L.F., et al. An acidic protein isolated from fibrous astrocytes. Brain Res. 1971, 28:351-354.
17. Eng L.F., et al. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 2000, 25:1439-1451.
18. Fletcher G.C., et al. The spectrin cytoskeleton regulates the hippo signalling pathway. EMBO J. 2015, 34:940-954.
19. Fuller G.N., Burger P.C. Central Nervous System. Histology for Pathologists 1997, 243-282. Lippincott-Raven, Philadelphia. 2nd ed. S.S. Sternberg (Ed.).
20. Gallagher P.G., et al. Genetic basis of the polymorphisms of the alpha I domain of spectrin. Am. J. Hematol. 1997, 56:107-111.
21. Giaume C., Venance L. Intercellular calcium signaling and gap junctional communication in astrocytes. Glia 1998, 24:50-64.
22. Glantz S.B., Morrow J.S. The Spectrin-Actin Cytoskeleton and Membrane Integrity in Hypoxia. Tissue Oxygen Deprivation 1996, 95:153-192. Marcel Dekker, New York. G.G. Haddad, G. Lister (Eds.).
23. Glantz S.B., et al. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochem. J. 2007, 46:502-513.
24. Gonzalez A., et al. Ethanol stimulates ROS generation by mitochondria through CA2+ mobilization and increases GFAP content in rat hippocampal astrocytes. Brain Res. 2007, 1178:28-37.
25. Gray B.C., et al. Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice. Biochem. Soc. Trans. 2006, 34:51-54.
26. Guo F., et al. Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis. J. Neurosci. 2011, 31:11914-11928.
27. Harris A.S., et al. The calmodulin-binding site in fodrin is near the site of calcium-dependent protease-I cleavage. J. Biol. Chem. 1988, 263:15754-15761.
28. Harris A.S., et al. Calmodulin regulates fodrin susceptibility to cleavage by calcium-dependent protease I. J. Biol. Chem. 1989, 264:17401-17408.
29. Harris A.S., Morrow J.S. Calmodulin and calcium-dependent protease I coordinately regulate the interaction of fodrin with actin. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3009-3013.
30. Hol E.M., Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr. Opin. Cell Biol. 2015, 32:121-130.
31. Hong S.C., et al. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia. Brain Res. 1994, 661:43-50.
32. Huh G.Y., et al. Calpain proteolysis of alpha II-spectrin in the normal adult human brain. Neurosci. Lett. 2001, 316:41-44.
33. Hwang I.K., et al. Alpha II-spectrin breakdown product increases in principal cells in the gerbil main olfactory bulb following transient ischemia. Neurosci. Lett. 2008, 435:251-256.
34. Imura T., et al. Phenotypic and functional heterogeneity of GFAP expressing cells in vitro: differential expression of LeX/CD15 by GFAP-expressing multipotent neural stem cells and non-neurogenic astrocytes. Glia 2006, 53:277-293.
35. Kang W., Hébert J.M. Signaling pathways in reactive astrocytes, a genetic perspective. Mol. Neurobiol. 2011, 43:147-154.
36. Kimelberg H. The problem of astrocyte identity. Neurochem. Int. 2004, 45:191-202.
37. Klepper S., et al. Verapamil treatment attenuates immunoreactive GFAP at cerebral cortical lesion site. Brain Res. 1995, 695:245-249.
38. Lencesova L., et al. Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. J. Biol. Chem. 2004, 279:2885-2893.
39. Machnicka B., et al. Spectrin-based skeleton as an actor in cell signaling. Cell. Mol. Life Sci. 2012, 69:191-201.
40. Mathewson A., Berry M. Preservation of the astrocyte response to a cerebral stab wound in adult rats. Brain Res. 1985, 327:61-69.
41. Matyash V., Kettenmann H. Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 2010, 63:2-10.
42. McGinn M.J., et al. Biochemical, structural and biomarker evidence for calpain-mediated cytoskeletal change following diffuse brain injury uncomplicated by contusion. J. Neuropathol. Exp. Neurol. 2009, 68:241-249.
43. Middeldorp J., Hol E.M. GFAP in health and disease. Prog. Neurobiol. 2011, 93:421-443.
44. Morrow J.S., et al. Of Membrane Stability and Mosaics: The Spectrin Cytoskeleton. Handbook of Physiology 1997, 485-540. London, Oxford. J. Hoffman, J. Jamieson (Eds.).
45. Nath R., et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 1996, 319:683-690.
46. Nedergaard M., et al. Glial calcium and diseases of the nervous system. Cell Calcium 2010, 47:140-149.
47. Nedrelow J.H., et al. c-Src binds alpha II spectrin's Src homology 3 (SH3) domain and blocks calpain susceptibility by phosphorylating Tyr1176. J. Biol. Chem. 2003, 278:7735-7741.
48. Nicolas G., et al. Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain. Mol. Cell. Biol. 2002, 22:3527-3536.
49. Oberheim N.A., et al. Uniquely hominid features of adult human astrocytes. J. Neurosci. 2009, 29:3276-3287.
50. Oberheim N.A., et al. Heterogeneity of astrocytic form and function. Methods Mol. Biol. 2012, 814:23-45.
51. Papal S., et al. The giant spectrin βV couples the molecular motors to phototransduction and usher syndrome type I proteins along their trafficking route. Hum. Mol. Genet. 2013, 22:3773-3788.
52. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
53. Pekny M., Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol. Rev. 2014, 94:1077-1098.
54. Pumplin D.W. The membrane skeleton of acetylcholine receptor domains in rat myotubes contains antiparallel homodimers of beta-spectrin in filaments quantitatively resembling those of erythrocytes. J. Cell Sci. 1995, 108:3145-3154.
55. Ramon y Cajal S. Histology of Nervous System of Man and Vertebrates 1995, Oxford University Press, London.
56. Shields D.C., et al. Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5768-5772.
57. Shields D.C., et al. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J. Neurosci. Res. 2000, 61:146-150.
58. Sofroniew M.V., Vinters H.V. Astrocytes: Biology and Pathology. Acta Neuropathol. 2010, 119:7-35.
59. Sofroniew M.V. Astrogliosis. Cold Spring Harb. Perspect. Biol. 2014, 7(2). Nov 7. 10.1101/cshperspect.a020420.
60. Stankewich M.C., et al. Targeted deletion of BIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes. PNAS 2010, 107:6022-6027.
61. Stankewich M.C., et al. Cell organization, growth, and neural and cardiac development require αII-spectrin. J. Cell Sci. 2011, 124(Pt 23):3956-3966.
62. Sun D., Jakobs T.C. Structural remodeling of astrocytes in the injured CNS. Neuroscientist 2012, 18:567-588.
63. Sun J., et al. A 10-minute prototype assay for tissue degradation monitoring in clinical specimens. Exp. Mol. Pathol. 2015, 99:86-94.
64. Tohyama J., et al. SPTAN1 encephalopathy: distinct phenotypes and genotypes. J. Hum. Genet. 2015, 60:167-173.
65. Vanderklish P.W., Bahr B.A. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 2000, 81:323-339.
66. Verkhrastsky A., et al. Glial calcium: homeostasis and signaling function. Physiol. Rev. 1998, 78:99-141.
67. Wang K.K.W., Yuen P. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol. Sci. 1994, 15:412-419.
68. Yeh T.-H., et al. Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. Glia 2009, 57:1239-1249.
69. Zhang Y., Barres B.A. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010, 20:588-594.